Description
A synthetic analog of human GHRH(1-44) stabilized by N-terminal trans-3-hexenoic acid. Approved as Egrifta for HIV-associated lipodystrophy and widely studied in visceral adipose tissue research.
A synthetic analog of human GHRH(1-44) stabilized by N-terminal trans-3-hexenoic acid. Approved as Egrifta for HIV-associated lipodystrophy and widely studied in visceral adipose tissue research.
A synthetic analog of human GHRH(1-44) stabilized by N-terminal trans-3-hexenoic acid. Approved as Egrifta for HIV-associated lipodystrophy and widely studied in visceral adipose tissue research.
| Strength | 5mg, 10mg |
|---|